Lifitegrast Approval Status
- FDA approved: No
- Generic name: lifitegrast
- Company: Shire plc
- Treatment for: Dry Eye Disease
Lifitegrast is a topical integrin antagonist in development for the treatment of dry eye disease.
FDA Approval Status for lifitegrast
|Mar 2, 2015||Shire Submits NDA to the FDA for Approval of Lifitegrast For Treatment of Dry Eye Disease in Adults|
|May 16, 2014||Shire Plans to Submit a New Drug Application to FDA for Lifitegrast for Dry Eye Disease in Adults|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.